Search

Search Results

• HIV-ASSOCIATED VENOUS THROMBOEMBOLISM

  Michele Bibas, Gianluigi Biava, Andrea Antinori

  e2011030

  2011-07-08

  https://doi.org/10.4084/mjhid.2011.030

  3751

  PDF: 1401

  HTML: 8482

• ANTITHROMBOTIC PROPHYLAXIS IN THE MIDDLE EAST

  Samir Arnaout, Hanady R. Samaha, Julien Succar, Imad Bou-Akl, Khaled M. Musallam, Ali T. Taher

  e2011023

  2011-05-23

  https://doi.org/10.4084/mjhid.2011.023

  1930

  PDF: 818

  HTML: 1324

• SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM

  Zohreh Rahimi, Abbas Parsian

  e2011024

  2011-05-23

  https://doi.org/10.4084/mjhid.2011.024

  2148

  PDF: 823

  HTML: 2057

• SECONDARY PROPHYLAXIS OF VENOUS THROMBOEMBOLISM (VTE) WITH LOW DOSE APIXABAN OR RIVAROXABAN: RESULTS FROM A PATIENT POPULATION WITH MORE THAN 2 YEARS OF MEDIAN FOLLOW-UP

  Alessandro Laganà, Giovanni Manfredi Assanto, Chiara Masucci, Mauro Passucci, Livia Donzelli, Alessandra Serrao, Erminia Baldacci, Cristina Santoro, Antonio Chistolini

  e2024020

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.020

  984

  PDF: 1193

  HTML: 87

• EPIDEMIOLOGY OF PROTHROMBIN G20210A MUTATION IN THE MEDITERRANEAN REGION

  Mehrez M. Jadaon

  e2011054

  2011-11-28

  https://doi.org/10.4084/mjhid.2011.054

  2615

  PDF: 1080

  HTML: 2779

• CURRENT ISSUES AND OPTIONS FOR HORMONAL CONTRACEPTION IN ADOLESCENTS AND YOUNG ADULT WOMEN WITH SICKLE CELL DISEASE: AN UPDATE FOR HEALTH CARE PROFESSIONALS Hormonal Contraception in Adolescents and Young Adult Women With Sickle Cell Disease

  Vincenzo De Sanctis

  e2020032

  2020-04-27

  https://doi.org/10.4084/mjhid.2020.032

  2052

  PDF: 1364

  HTML: 670

• THALASSEMIA AND VENOUS THROMBOEMBOLISM

  Julien Succar, Khaled M. Musallam, Ali T Taher

  e2011025

  2011-05-25

  https://doi.org/10.4084/mjhid.2011.025

  2850

  PDF: 973

  HTML: 4558

• EPIDEMIOLOGY OF ACTIVATED PROTEIN C RESISTANCE AND FACTOR V LEIDEN MUTATION IN THE MEDITERRANEAN REGION

  Mehrez Mehrez M. Jadaon

  e2011037

  2011-09-08

  https://doi.org/10.4084/mjhid.2011.037

  3053

  PDF: 762

  HTML: 12866

• BACTERIAL INFECTIONS FOLLOWING SPLENECTOMY FOR MALIGNANT AND NONMALIGNANT HEMATOLOGIC DISEASES

  Giuseppe Leone, Eligio Pizzigallo

  e2015057

  2015-10-12

  https://doi.org/10.4084/mjhid.2015.057

  4628

  PDF: 1904

  HTML: 8269

• DIRECT ORAL ANTICOAGULANTS IN PATIENTS AFFECTED BY MAJOR CONGENITAL THROMBOPHILIA

  alessandra serrao, benedetta lucani, davide mansour, antonietta ferretti, erminia baldacci, cristina santoro, robin foà, antonio chistolini

  e2019044

  2019-06-25

  https://doi.org/10.4084/mjhid.2019.044

  1889

  PDF: 1462

  HTML: 424

• Acute Cytomegalovirus infection as a cause of venous thromboembolism

  Raffaella Lissandrin, Francesco Mojoli, Fausto Baldanti, Enrico Brunetti, Michela Pascarella, Maria Teresa Giordani, Francesca Rinaldi

  e2014041

  2014-05-30

  https://doi.org/10.4084/mjhid.2014.041

  1467

  PDF: 812

  HTML: 1010

  Picture 1: 150

• BEHÇET’S SYNDROME AND THROMBOSIS

  Emire Seyahi, Sebahattin Yurdakul

  e2011026

  2011-07-08

  https://doi.org/10.4084/mjhid.2011.026

  2741

  PDF: 1593

  HTML: 16947

• Direct oral anticoagulants (DOACs) in the onco-hematologic patients

  Mario Biglietto, Silvio Ligia, Alessandro Laganà, Giovanni Manfredi Assanto, Martina Gherardini, Erminia Baldacci, Cristina Santoro, Antonio Chistolini

  e2025022

  2025-02-27

  https://doi.org/10.4084/MJHID.2025.022

  938

  PDF: 930

  HTML: 74

• SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology

  Firas Kreidieh, Sally Temraz

  e2020078

  2020-10-27

  https://doi.org/10.4084/mjhid.2020.078

  976

  PDF: 930

  HTML: 297

• MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS

  Lucio Amitrano, Maria Anna Guardascione

  e2009014

  https://doi.org/10.4084/mjhid.2009.014

  783

  PDF: 519

  HTML: 4002

• HOW THE HEMOSTASIS LABORATORY CAN HELP CLINICIANS TO MANAGE PATIENTS ON ORAL ANTICOAGULANTS

  Armando Tripodi

  e2024027

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.027

  950

  PDF: 1290

  HTML: 106

• ASSOCIATION BETWEEN HEPARIN DOSE AND 6-WEEKS MORTALITY IN PATIENTS WITH COVID-19

  Claire Coutureau, Philippe Nguyen, Maxime Hentzien, Peter Joe Noujaim, Sarah Zerbib, Damien Jolly, Lukshe Kanagaratnam

  e2022036

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.036

  786

  PDF: 476

  HTML: 346

• Protein S deficiency with recurrent thromboembolism in a patient with hemoglobin H disease following splenectomy

  Kun Yang

  e2024017

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.017

  550

  PDF: 1027

  HTML: 54

• Evaluation of VTE-PREDICT risk score in patients receiving low-dose DOACs for venous thromboembolism (VTE) secondary prophylaxis

  Alessandro Laganà, Giovanni Manfredi Assanto, Mauro Passucci, Cristina Santoro, Antonio Chistolini

  e2024047

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.047

  1095

  PDF: 943

  HTML: 73

• THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis

  Nicola Semeraro, Prof. Mario Colucci

  e2021045

  2021-06-28

  https://doi.org/10.4084/MJHID.2021.045

  1846

  PDF: 762

  HTML: 204

• PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID

  Francesco Rodeghiero

  e2021032

  2021-04-29

  https://doi.org/10.4084/MJHID.2021.032

  2269

  PDF: 869

  HTML: 462

• Correlation to FVIII:C in two thrombin generation tests: TGA-CAT and INNOVANCE ETP

  Marcus Ljungkvist

  e2017064

  2017-11-01

  https://doi.org/10.4084/mjhid.2017.064

  2161

  PDF: 749

  HTML: 844

  Figure 2: 195

  Figure 1: 151

• BASELINE THROMBIN GENERATION TEST DOES NOT PREDICT THROMBOTIC EVENTS IN ACUTE LEUKEMIA: A MONOCENTRIC PROSPECTIVE STUDY

  Mario Biglietto, Rosaria Mormile, Maria Laura Bisegna, Alessandro Laganà, Anna Laura Faccini, Andrea Papa, Erminia Baldacci, Cristina Santoro, Maria Stefania De Propris, Antonio Chistolini

  e2025076

  2025-10-31

  https://doi.org/10.4084/MJHID.2025.076

  329

  PDF: 151

  Html: 34

• THE PERFORMANCE OF 2023 AMERICAN COLLEGE OF RHEUMATOLOGY (ACR) / EUROPEAN ALLIANCE OF ASSOCIATIONS FOR RHEUMATOLOGY (EULAR) ANTIPHOSPHOLIPID SYNDROME CLASSIFICATION CRITERIA IN A REAL-WORLD RHEUMATOLOGY DEPARTMENT

  Ahmet Usta, Müçteba Enes Yayla, Emine Uslu, Serdar Sezer, Ebru Us, Aşkın Ateş, Murat Turgay

  e2024074

  2024-10-31

  https://doi.org/10.4084/MJHID.2024.074

  1259

  PDF: 608

  Suppl. Files: 333

  HTML: 194

• COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES

  M. Domenica Cappellini, Khaled M. Musallam, Alessia Marcon, Ali Taher

  e2009029

  2009-12-28

  1029

  PDF: 466

  HTML: 8132

• CARDIAC FUNCTION AND IRON CHELATION IN THALASSEMIA MAJOR AND INTERMEDIA: A REVIEW OF THE UNDERLYING PATHOPHYSIOLOGY AND APPROACH TO CHELATION MANAGEMENT

  Athanasios Aessopos, Vasilios Berdoukas

  e2009002

  2009-07-18

  1513

  PDF: 461

  HTML: 1423

• SEPSIS-ASSOCIATED DISSEMINATED INTRAVASCULAR COAGULATION AND THROMBOEMBOLIC DISEASE

  Nicola Semeraro, Concetta T. Ammollo, Fabrizio Semeraro, Mario Colucci

  e2010024

  2010-08-06

  https://doi.org/10.4084/mjhid.2010.024

  3154

  PDF: 1593

  HTML: 4367

• IS THE INCIDENCE TREND OF HEPARIN-INDUCED THROMBOCYTOPENIA DECREASED BY THE INCREASED USE OF LOW-MOLECULAR-WEIGHT-HEPARIN?

  Fahad Al-Eidan

  e2015029

  2015-04-19

  https://doi.org/10.4084/mjhid.2015.029

  1560

  PDF: 785

  HTML: 1453

• PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA

  Anna Falanga, Laura Russo, Carmen J Tartari

  e2011068

  2011-12-21

  https://doi.org/10.4084/mjhid.2011.068

  1712

  PDF: 775

  HTML: 10200

  Figures 1,2,3: 150

• CEREBRAL VENOUS THROMBOSIS IN THE MEDITERRANEAN AREA IN CHILDREN

  S Menascu, A Lotan, B Ben Zeev, U Nowak- Gottl, G Kenet

  e2011029

  2011-07-08

  https://doi.org/10.4084/mjhid.2011.029

  2456

  PDF: 918

  HTML: 2210

• REVIEW AND RECOMMENDATIONS ON MANAGEMENT OF ADULT FEMALE THALASSEMIA PATIE?TS WITH HYPOGONADISM BASED ON LITERATURE REVIEW AND EXPERIENCE OF ICET-A NETWORK SPECIALISTS

  Vincenzo De Sanctis

  e2017001

  2017-01-01

  https://doi.org/10.4084/mjhid.2017.001

  5984

  PDF: 1388

  HTML: 1915

• CLINICAL CARE PATHWAY AND MANAGEMENT OF MAJOR BLEEDING ASSOCIATED WITH NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS: A MODIFIED DELPHI CONSENSUS FROM SAUDI ARABIA AND UAE

  Abdulrahman Al Raizah, Fakhr Alayoubi, Galal Hassan Abdelnaby, Hazzaa Alzahrani, Majid Farraj Bakheet, Mohammed A Alskaini, Rasha Buhumaid, Sameer Al Awadhi, Sara Nooruddin Kazim, Thiagarajan Jaiganesh, Zohair Al Asiri

  e2024038

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.038

  2516

  PDF: 1122

  HTML: 95

• MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA Guest Editor: Giancarlo Costaman

  Davide Matino, Paul Tieu, Dr., Antony Chan

  e2020001

  2020-01-01

  https://doi.org/10.4084/mjhid.2020.001

  3011

  PDF: 1549

  HTML: 385

• ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY   Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.

  Ming Tong, Xiquan Yan, Yu Jiang, Zhaoxia Jin, Shengjiao Zhu, Lianhong Zou, Yanjuan Liu, Qing Zheng, Guoqiang Chen, Ruifeng Gui Gui, Zhilan Zhou, Xiaotong Han, Jiangming He, Siqing Yin, Changchun Ma, Wen Xiao, Yong Zeng, Fang Chen, Yimin Zhu

  e2022033

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.033

  1164

  PDF: 697

  HTML: 281

• CEREBRAL VENOUS THROMBOSIS IN THE MEDITERRANEAN AREA IN ADULTS

  Nilüfer Yeşilot Barlas, Gülşen Akman-Demir, Sara Zarko Bahar

  e2011044

  2011-10-24

  https://doi.org/10.4084/mjhid.2011.044

  2194

  PDF: 727

  HTML: 1235

• THALASSAEMIA INTERMEDIA : AN UPDATE

  Ali Taher, Khaled M. Musallam, Maria Domenica Cappellini

  e2009004

  2009-08-17

  1006

  PDF: 424

  HTML: 9403

• Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA

  Bhavya S Doshi, Valder R Arruda, Valder R Arruda

  e2020069

  2020-09-08

  https://doi.org/10.4084/mjhid.2020.069

  1932

  PDF: 1800

  HTML: 324

• THE TREATMENT OF MULTIPLE MYELOMA PATIENTS NOT ELIGIBLE FOR ASCT

  Paul Richardson, Jacob Laubach, Anuj Mahindra, Constantine Mitsiades, Robert Schlossman, Irene Ghobrial, Teru Hideshima, Noopur Raje, Nikhil Munshi, Kenneth Anderson

  e2010009

  2010-05-03

  https://doi.org/10.4084/mjhid.2010.009

  1014

  PDF: 675

  HTML: 598

• COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.

  Federico Mercolini, Simone Cesaro

  e2022009

  2022-01-01

  https://doi.org/10.4084/MJHID.2022.009

  1951

  PDF: 896

  HTML: 276

• INCREASED VASOOCCLUSIVE CRISIS IN “O” BLOOD GROUP SICKLE CELL DISEASE PATIENTS: ASSOCIATION WITH UNDERLYING THROMBOSPONDIN LEVELS.

  M. Al Huneini, Anil Pathare

  e2017028

  2017-04-20

  https://doi.org/10.4084/mjhid.2017.028

  1889

  PDF: 877

  HTML: 1346

• COMBINED MODALITY TREATMENT INCLUDING METHOTREXATE-BASED CHEMOTHERAPY FOR PRIMARY CEREBRAL NERVOUS SYSTEM LYMPHOMA: A SINGLE INSTITUTION EXPERIENCE

  Stefan Hohaus, Luciana Teofili, Mario Balducci, Stefania Manfrida, Angelo Pompucci, Francesco D'Alo', Giuseppina Massini, Luigi Maria Larocca, Roberto Marra, Sergio Storti

  e2009020

  2009-12-14

  https://doi.org/10.4084/mjhid.2009.020

  2023

  PDF: 515

  HTML: 2271

• ON THE VERSATILITY OF VON WILLEBRAND FACTOR

  Antoine Rauch, Peter Lenting

  e2013046

  2013-07-10

  https://doi.org/10.4084/mjhid.2013.046

  2720

  PDF: 1075

  HTML: 11203

• REAL WORLD DATA ON CHARACTERISTICS AND MANAGEMENT OF COMMUNITY PATIENTS RECEIVING ANTICOAGULATION THERAPY WHO PRESENTED WITH ACUTE BLEEDING TO THE EMERGENCY DEPARTMENT AT A REGIONAL AUSTRALIAN HOSPITAL: A PROSPECTIVE OBSERVATIONAL STUDY. Anticoagulation and bleeding ?

  Fayez Hanna, Annemarie Hyppa, Ajay Prakash, Usira Vithanarachchi, Hizb U Dawar, Zar Sanga, George Olabode, Hamish Crisp, Professor Alhossain A. Khalafallah

  e2021017

  2021-02-26

  https://doi.org/10.4084/mjhid.2021.017

  1474

  PDF: 496

  HTML: 279

• Thalidomide treatment for thrombocytopenia secondary to hypersplenism in children with β-thalassemia major: a case series Thalidomide treatment for thrombocytopenia

  Kun Yang

  e2025037

  2025-04-30

  https://doi.org/10.4084/MJHID.2025.037

  820

  PDF: 684

  HTML: 95

• Microangiopathic Hemolytic Anemia in 57-year-old woman with Borderline Serous Tumor of the Ovary:Real-Time Management of Common Pathways of Hemostatic Failure

  Gloria Joan Morris

  e2012030

  2012-05-06

  https://doi.org/10.4084/mjhid.2012.030

  1046

  PDF: 764

  HTML: 12713

• High Prevalence of Antiphospholipid Antibodies in Children with Non-Transfusion Dependent Thalassemia and Possible Correlations with Microparticles Antiphospholipid Antibodies and Thalassemia in children

  Jitlada Chinsuwan, Phatchanat Klaihmon, Praguywan Kadegasem, Ampaiwan Chuansumrit, Anucha Soisamrong, Kovit Pattanapanyasat, Pakawan Wongwerawattanakoon, Nongnuch Sirachainan

  e2020071

  2020-10-27

  https://doi.org/10.4084/mjhid.2020.071

  782

  PDF: 552

  HTML: 259

• Is laboratory monitoring useful in DOACs management?

  Mario Biglietto, Rosaria Mormile, Matteo Totaro, Maria Laura Bisegna, Cristina Santoro, Antonio Chistolini

  e2025019

  2025-02-27

  https://doi.org/10.4084/MJHID.2025.019

  764

  PDF: 763

  HTML: 94

• IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA: PATHOPHYSIOLOGY, DIAGNOSIS AND OPEN ISSUES

  Silvia Maria Trisolini, Alessandro Laganà, Saveria Capria

  e2024060

  2024-06-29

  https://doi.org/10.4084/MJHID.2024.060

  1912

  PDF: 1694

  HTML: 115

• USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS

  Paola Mancino, Katia Falasca, Claudio Ucciferri, Eligio Pizzigallo, Jacopo Vecchiet

  e2010003

  2010-03-26

  https://doi.org/10.4084/mjhid.2010.003

  1018

  PDF: 485

  HTML: 802

• Successful treatment of gastric relapse in multiple myeloma with bortezomib after autologous hematopoietic stem cell transplantation (autoHSCT)

  Serdar Sivgin

  e2013006

  2013-01-02

  https://doi.org/10.4084/mjhid.2013.006

  1090

  PDF: 586

  HTML: 3217